Bio-Gene Technology Limited (BGT.AX)
AUD 0.03
(0.0%)
AUD 0.03
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -2.4 Million AUD | 22.18% |
| 2023 | -3.09 Million AUD | -10.49% |
| 2022 | -2.8 Million AUD | -18.82% |
| 2021 | -2.35 Million AUD | -26.11% |
| 2020 | -1.86 Million AUD | 2.6% |
| 2019 | -1.91 Million AUD | 32.24% |
| 2018 | -2.83 Million AUD | -168.56% |
| 2017 | -1.05 Million AUD | -227.08% |
| 2016 | -322.51 Thousand AUD | -228.23% |
| 2015 | -98.26 Thousand AUD | -12.55% |
| 2014 | -87.3 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.5 Million AUD | 0.0% |
| 2024 FY | -2.4 Million AUD | 22.18% |
| 2024 Q4 | -899.96 Thousand AUD | 0.0% |
| 2023 Q2 | -1.97 Million AUD | 0.0% |
| 2023 FY | -3.09 Million AUD | -10.49% |
| 2023 Q4 | -1.12 Million AUD | 0.0% |
| 2022 Q2 | -1.43 Million AUD | 0.0% |
| 2022 FY | -2.8 Million AUD | -18.82% |
| 2022 Q4 | -1.47 Million AUD | 0.0% |
| 2021 Q4 | -1.06 Million AUD | 0.0% |
| 2021 Q1 | -483.27 Thousand AUD | 44.58% |
| 2021 FY | -2.35 Million AUD | -26.11% |
| 2021 Q2 | -1.32 Million AUD | -175.1% |
| 2020 Q2 | -1.06 Million AUD | 0.0% |
| 2020 Q4 | -871.95 Thousand AUD | -80.43% |
| 2020 Q3 | -483.27 Thousand AUD | 54.46% |
| 2020 FY | -1.86 Million AUD | 2.6% |
| 2019 Q3 | -513.89 Thousand AUD | 59.42% |
| 2019 FY | -1.91 Million AUD | 32.24% |
| 2019 Q4 | -789.25 Thousand AUD | -53.58% |
| 2019 Q2 | -1.26 Million AUD | 0.0% |
| 2018 Q4 | -1.28 Million AUD | -81.25% |
| 2018 FY | -2.83 Million AUD | -168.56% |
| 2018 Q2 | -1.54 Million AUD | 0.0% |
| 2018 Q3 | -708.26 Thousand AUD | 54.29% |
| 2017 Q4 | -740.82 Thousand AUD | 0.0% |
| 2017 FY | -1.05 Million AUD | -227.08% |
| 2017 Q2 | -314.07 Thousand AUD | 0.0% |
| 2016 FY | -322.51 Thousand AUD | -228.23% |
| 2015 FY | -98.26 Thousand AUD | -12.55% |
| 2014 FY | -87.3 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | 55.23% |
| Acrux Limited | -5.8 Million AUD | 58.462% |
| Race Oncology Limited | -13.81 Million AUD | 82.567% |
| Biome Australia Limited | -1.67 Million AUD | -44.245% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | 82.63% |
| BTC Health Limited | 1.05 Million AUD | 328.296% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | 80.772% |
| CSL Limited | 2.64 Billion AUD | 100.091% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 94.308% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 106.76% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 134.592% |
| Hexima Limited | -933.87 Thousand AUD | -157.977% |
| Immutep Limited | -39.89 Million AUD | 93.961% |
| Memphasys Limited | -4.44 Million AUD | 45.764% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 101.534% |
| Noxopharm Limited | -3.57 Million AUD | 32.669% |
| Prescient Therapeutics Limited | -8.23 Million AUD | 70.755% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 94.976% |
| Starpharma Holdings Limited | -8.16 Million AUD | 70.494% |
| Tissue Repair Ltd | -4.13 Million AUD | 41.781% |
| Biotron Limited | -3.43 Million AUD | 29.895% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 87.402% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -66.008% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 93.412% |
| Patrys Limited | -3.53 Million AUD | 31.928% |
| Orthocell Limited | -7.18 Million AUD | 66.45% |
| Imugene Limited | -149.68 Million AUD | 98.39% |
| PYC Therapeutics Limited | -37.72 Million AUD | 93.614% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | 62.216% |
| Cynata Therapeutics Limited | -9.74 Million AUD | 75.277% |
| Arovella Therapeutics Limited | -8.74 Million AUD | 72.454% |
| Nanollose Limited | -1.15 Million AUD | -108.307% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -46.739% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 843.092% |
| Amplia Therapeutics Limited | -4.5 Million AUD | 46.504% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | 15.89% |
| Nyrada Inc. | -1.38 Million AUD | -73.794% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 146.233% |
| Dimerix Limited | -17.07 Million AUD | 85.891% |
| PharmAust Limited | -9.03 Million AUD | 73.327% |
| AnteoTech Limited | -8.88 Million AUD | 72.871% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 95.893% |
| Recce Pharmaceuticals Ltd | -17.66 Million AUD | 86.359% |
| Avecho Biotechnology Limited | -3.43 Million AUD | 29.896% |
| Actinogen Medical Limited | -13.04 Million AUD | 81.531% |
| Immuron Limited | -6.93 Million AUD | 65.27% |
| Argenica Therapeutics Limited | -5.47 Million AUD | 56.033% |